GHK-Cu

GHK-Cu is a small three-amino-acid peptide bound to a copper ion. The peptide, GHK, was first isolated from human plasma in 1973 by Loren Pickart, who later identified that the active species was the copper-bound form. It exists naturally in your skin and falls with age. Most of the rigorous published work sits in dermatology and cosmetic literature and focuses on the topical form, documenting effects on collagen and decorin synthesis, dermal extracellular matrix remodeling, and hair follicle activity. We use both topical preparations and the injectable subcutaneous form, depending on what a patient is after. Injectable dosing runs 5 days on and 2 days off, in cycles of 8 to 12 weeks. Protocols here are supervised by Dr. Oliver Morris, our Medical Director.

It is not. GHK-Cu is not an FDA-approved drug, and that belongs at the front of any conversation about it. It has not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease, and we treat its use as investigational and as part of an individualized wellness plan. Sourcing is a separate question from approval, and it matters just as much. Our peptides come through specialty peptide distributors that run Certificate of Analysis testing on every lot to confirm identity, purity, and concentration, and that operate under the regulatory and quality standards applicable to their industry. The vials we would tell you to avoid are the ones sold online without a prescription, where you cannot verify contents, purity, or sterility.

The topical form is where the strongest published evidence sits, and it is appropriate for many more patients than the injectable. That is worth saying plainly. Injectable systemic GHK-Cu has a thinner evidence base. Most of what we know about it comes from clinical experience and from the topical mechanism literature, not from large randomized human trials of the injection itself. In practice, most of our patients use both: a topical serum at home, especially around microneedling and laser sessions, with the injectable running underneath as a daily layer, 5 days on and 2 days off. The topical and the injectable work different parts of the same problem, and pairing them is how most patients here structure a plan. If you only want one, topical is the easier starting point.

Most patients describe skin texture changes around weeks 6 to 8 of consistent use. A cycle runs 8 to 12 weeks with breaks between courses, and that length is set on purpose. Skin remodeling is slow, and the cycle matches the time collagen and dermal matrix changes take to show up. What patients report over a cycle: improvements in skin texture, firmness, and tone, subjective gains in hair density and scalp condition, better post-procedure recovery alongside microneedling and lasers, and support for fine lines and crepiness. Effects build over weeks rather than appearing suddenly. Response is individual and we do not guarantee outcomes. If you are in an active treatment series, GHK-Cu is usually the background layer while procedures do the visible work.

If you have Wilson's disease or a known copper sensitivity, we do not use this peptide. The copper component is a small dose, but the principle still applies, and that includes anyone who has been treated for a copper-related condition. We also avoid it in pregnancy and breastfeeding, where there is no safety data. Beyond that, we are more cautious about systemic injection than about topical use in patients with recent malignancy. Injection-site reactions and a short-term flush are possible in some users. For patients who do not fit the injectable, the topical preparation is often still reasonable, and that is a conversation worth having rather than dropping GHK-Cu entirely. Bring your history to the consultation, including any copper-related diagnoses.

We price it at the consultation instead of posting a figure, because there are two products here and the plan decides the cost. A topical serum used at home and an 8 to 12 week injectable cycle dosed 5 days on and 2 days off are different commitments. Most patients run both, and most are also paying for the procedures GHK-Cu is meant to support, whether that is microneedling, RF microneedling, or a laser series. Pricing the peptide in isolation gives you a misleading picture. At the visit we will go through what you are already doing for your skin, where GHK-Cu fits, whether topical alone is enough to start, and what a full cycle would run. Call the Palm Harbor office to get on the schedule.